Total entries:  6813
DRACP ID Peptide Name Sequence Sequence Length C terminal
DRACP02851 Arenicin-3 [Y5N,Y9R,Y17H], NZ17143 GFCWNVCVRRNGVRVCHRRCN 21 Free
DRACP02852 Arenicin-3 [Y9K,V15S], NZ17160 GFCWYVCVKRNGVRSCYRRCN 21 Free
DRACP02853 Arenicin-3 [Y5N,V15I,Y17H], NZ17211 GFCWNVCVYRNGVRICHRRCN 21 Free
DRACP02854 Arenicin-3 [Y5H,V8A,Y9], NZ17224 GFCWHVCARRNGVRVCYRRCN 21 Free
DRACP02855 Arenicin-3 [Y5R;V6,15A], NZ17228 GFCWRACVYRNGVRACYRRCN 21 Free
DRACP02856 Arenicin-3 [Y5R,V6A], NZ17230 GFCWRACVYRNGVRVCYRRCN 21 Free
DRACP02857 Ixosin GLHKVMREVLGYERNSYKKFFLR 23 Amidation
DRACP02858 Ixosin [H3A] GLAKVMREVLGYERNSYKKFFLR 23 Amidation
DRACP02859 Ixosin (4-23) KVMREVLGYERNSYKKFFLR 20 Amidation
DRACP02860 Ixosin [E8K,E13L,S16V], Ixosin-pch GLHKVMRKVLGYLRNVYK 18 Amidation
DRACP02861 Ixosin [H3A,E8K,E13L,S16V], Ixosin-pch-H3A GLAKVMRKVLGYLRNVYK 18 Amidation
DRACP02862 Ixosin (4-18)[E8K,E13L,S16V], Ixosin-pch4–18 KVMRKVLGYLRNVYK 15 Amidation
DRACP02863 Ixosin (1-12) GLHKVMREVLGY 12 Amidation
DRACP02864 Ixosin (12-23) YERNSYKKFFLR 12 Amidation
DRACP02865 Ixosin (1-18) GLHKVMREVLGYERNSYK 18 Amidation
DRACP02866 Ixosin (4-18) KVMREVLGYERNSYK 15 Amidation
DRACP02867 Ixosin (7-18) REVLGYERNSYK 12 Amidation
DRACP02868 LL-37 (17-29) [F17L] LKRIVQRIKDFLR 13 Amidation
DRACP02869 LL-37 (17-29) [F17A] AKRIVQRIKDFLR 13 Amidation
DRACP02870 LL-37 (17-29) [K25L] FKRIVQRILDFLR 13 Amidation
DRACP02871 LL-37 (17-29) [18SA-K] [K25L] FXRIVQRILDFLR 13 Amidation
DRACP02872 LL-37 (17-29) [K25R] FKRIVQRIRDFLR 13 Amidation
DRACP02873 LL-37 (17-29) [K25R]-Ac FKRIVQRIRDFLR 13 Amidation
DRACP02874 LL-37 (17-29) [R23K] FKRIVQKIKDFLR 13 Amidation
DRACP02875 LL-37 (17-29) [R23L] FKRIVQLIKDFLR 13 Amidation
DRACP02876 LL-37 (17-29) [R23L]-Ac FKRIVQLIKDFLR 13 Amidation
DRACP02877 LL-37 (17-29) [F27L] FKRIVQRIKDLLR 13 Amidation
DRACP02878 LL-37 (17-29) [F27L]-Ac FKRIVQRIKDLLR 13 Amidation
DRACP02879 LL-37 (17-29) [R23I,D26K] FKRIVQIIKKFLR 13 Amidation
DRACP02880 LL-37 (17-29) [R23I,D26K]-Ac FKRIVQIIKKFLR 13 Amidation
<< < 94 95 96 97 98 >>

DRACP is developed by Dr.Zheng's team.